Studies on p53, BAX <strong>and</strong> Bcl-2 prote<strong>in</strong> expression <strong>and</strong> microsatellite <strong>in</strong>stability<strong>in</strong> stage III (UICC) colon cancer treated by adjuvant chemotherapy: majorprog<strong>no</strong>stic impact of proapoptotic BAX. Br J Cancer 96(9): 1409-141824. Gao J, Zhang H, Arbman G, Sun XF (2008) RAD50/MRE11/NBS1 prote<strong>in</strong>s <strong>in</strong>relation to tumour development <strong>and</strong> prog<strong>no</strong>sis <strong>in</strong> patients with microsatellitestable colorectal cancer. Histol Histopathol 23(12): 1495-150225. Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, S<strong>and</strong>ler RS, Carethers JM(2004) Loss of activ<strong>in</strong> receptor type 2 prote<strong>in</strong> expression <strong>in</strong> microsatelliteunstable colon cancers. Gastroenterology 126(3): 654-65926. Io<strong>no</strong>v Y, Matsui S, Cowell JK (2004) A role for p300/CREB b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong> genes<strong>in</strong> promot<strong>in</strong>g cancer progression <strong>in</strong> colon cancer cell l<strong>in</strong>es with microsatellite<strong>in</strong>stability. Proc Natl Acad Sci U S A 101(5): 1273-127827. Comai L, Zomerdijk JC, Beckmann H, Zhou S, Admon A, Tjian R (1994)Reconstitution of transcription factor SL1: exclusive b<strong>in</strong>d<strong>in</strong>g of TBP by SL1 orTFIID subunits. Science 266(5193): 1966-197228. Gorski JJ, Pathak S, Pa<strong>no</strong>v K, Kasciukovic T, Pa<strong>no</strong>va T, Russell J, Zomerdijk JC(2007) A <strong>no</strong>vel TBP-associated factor of SL1 functions <strong>in</strong> RNA polymerase Itranscription. EMBO J 26(6): 1560-156829. Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, Fior<strong>in</strong>o A, Smith EJ, Bocanegra M,Carethers JM (2007) Activ<strong>in</strong> type 2 receptor restoration <strong>in</strong> MSI-H colon cancersuppresses growth <strong>and</strong> enhances migration with activ<strong>in</strong>. Gastroenterology 132(2):633-64430. Helleday T, Lo J, van G, Engelward BP (2007) DNA double-str<strong>and</strong> break repair:from mechanistic underst<strong>and</strong><strong>in</strong>g to cancer treatment. DNA Repair (Amst) 6(7):923-93531. Lothe RA, Peltomäki P, Mel<strong>in</strong>g GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L,Heimdal K, Andersen TI, Moller P, Rognum TO, . (1993) Ge<strong>no</strong>mic <strong>in</strong>stability <strong>in</strong>colorectal cancer: relationship to cl<strong>in</strong>icopathological variables <strong>and</strong> familyhistory. Cancer Res 53(24): 5849-585232. Ahlquist T, L<strong>in</strong>d GE, Costa VL, Mel<strong>in</strong>g GI, Vatn M, Hoff GS, Rognum TO, SkotheimRI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of <strong>no</strong>rmal mucosa, <strong>and</strong>benign <strong>and</strong> malignant colorectal tumors identify early onset markers. Molecularcancer. In press33. Kim NG, Rhee H, Li LS, Kim H, Lee JS, Kim JH, Kim NK, Kim H (2002)Identification of MARCKS, FLJ11383 <strong>and</strong> TAF1B as putative <strong>no</strong>vel target genes<strong>in</strong> colorectal carc<strong>in</strong>omas with microsatellite <strong>in</strong>stability. Oncogene 21(33): 5081-508726
34. Mart<strong>in</strong>eau-Thuillier S, Andreassen PR, Margolis RL (1998) Colocalization of TD-60<strong>and</strong> INCENP throughout G2 <strong>and</strong> mitosis: evidence for their possible<strong>in</strong>teraction <strong>in</strong> signall<strong>in</strong>g cytok<strong>in</strong>esis. Chromosoma 107(6-7): 461-47035. Moll<strong>in</strong>ari C, Reynaud C, Mart<strong>in</strong>eau-Thuillier S, Monier S, Kieffer S, Gar<strong>in</strong> J,Andreassen PR, Boulet A, Goud B, Kleman JP, Margolis RL (2003) The mammalianpassenger prote<strong>in</strong> TD-60 is an RCC1 family member with an essential role <strong>in</strong>prometaphase to metaphase progression. Dev Cell 5(2): 295-30736. Rosasco-Nitcher SE, Lan W, Khorasanizadeh S, Stukenberg PT (2008) CentromericAurora-B activation requires TD-60, microtubules, <strong>and</strong> substrate prim<strong>in</strong>gphosphorylation. Science 319(5862): 469-47237. Hughes TA (2006) Regulation of gene expression by alternative untranslatedregions. Trends Genet 22(3): 119-12238. Picker<strong>in</strong>g BM, Willis AE (2005) The implications of structured 5' untranslatedregions on translation <strong>and</strong> disease. Sem<strong>in</strong> Cell Dev Biol 16(1): 39-4739. Wilkie GS, Dickson KS, Gray NK (2003) Regulation of mRNA translation by 5'-<strong>and</strong> 3'-UTR-b<strong>in</strong>d<strong>in</strong>g factors. Trends Biochem Sci 28(4): 182-18840. Suraweera N, Iacopetta B, Duval A, Compo<strong>in</strong>t A, Tubacher E, Hamel<strong>in</strong> R (2001)Conservation of mo<strong>no</strong>nucleotide repeats with<strong>in</strong> 3' <strong>and</strong> 5' untranslated regions<strong>and</strong> their <strong>in</strong>stability <strong>in</strong> MSI-H colorectal cancer. Oncogene 20(51): 7472-747727
- Page 1 and 2:
Novel genetic and epigenetic altera
- Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8:
Prefacetechnology[3]. This new tech
- Page 10 and 11:
SummaryThe subgroup of carcinomas w
- Page 12 and 13:
Introduction“Epigenetic inheritan
- Page 14 and 15:
Introductionamino acid change it is
- Page 16 and 17:
Introductionmethylation during embr
- Page 18 and 19:
IntroductionDNA is most of the time
- Page 20 and 21:
IntroductionFigure 5. DNA methylati
- Page 22 and 23:
IntroductionFigure 6. Incidence rat
- Page 24 and 25:
IntroductionFigure 8. Tumor staging
- Page 26 and 27:
Introductioninasmuch as 80% of colo
- Page 28 and 29:
IntroductionInstabilities involved
- Page 30 and 31:
Introductionthere seems to be a fid
- Page 32 and 33:
Introductionsevere alterations are
- Page 34 and 35:
Introductionpopulation-wide screeni
- Page 36 and 37:
IntroductionFigure 12. Present and
- Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41:
Results in Briefinstability, and se
- Page 42 and 43:
Results in BriefUnivariate survival
- Page 44 and 45:
Discussionseveral factors, and full
- Page 46 and 47:
Discussionlow threshold, we increas
- Page 48 and 49:
DiscussionIt may seem like unnecess
- Page 50 and 51:
Discussionthan 96% DHPLC do not sta
- Page 52 and 53:
DiscussionFigure 13. Mutation detec
- Page 54 and 55:
DiscussionClinical impact of molecu
- Page 56 and 57:
Discussionmarkers with a very high
- Page 58 and 59:
Discussionchromosomes in metaphase[
- Page 60 and 61:
DiscussionThese examples underline
- Page 62 and 63:
Discussiongenes. One is based on mu
- Page 64 and 65:
CONCLUSIONSWe have identified novel
- Page 66 and 67:
Future PerspectivesMolecular risk a
- Page 68 and 69:
REFERENCES1. Breasted J (1930) The
- Page 70 and 71:
References29. Deng G, Chen A, Pong
- Page 72 and 73:
References57. Al-Sukhni W, Aronson
- Page 74 and 75:
References84. Kunkel TA (1993) Nucl
- Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
- Page 78 and 79:
References133. Lind GE, Thorstensen
- Page 80 and 81:
References156. Meling GI, Lothe RA,
- Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85:
References196. Honda S, Haruta M, S
- Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
- Page 91:
Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95:
Journal of Translational Medicine 2
- Page 96 and 97:
Journal of Translational Medicine 2
- Page 98 and 99:
Journal of Translational Medicine 2
- Page 100 and 101:
Journal of Translational Medicine 2
- Page 102 and 103:
Journal of Translational Medicine 2
- Page 105: Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109: BackgroundMost cases of colorectal
- Page 110 and 111: ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113: pseudogene, leading to a high rate
- Page 114 and 115: strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117: concomitant absence of transcript a
- Page 119 and 120: Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122: 682 RAS Signaling in Colorectal Car
- Page 123 and 124: 684 RAS Signaling in Colorectal Car
- Page 125 and 126: 686 RAS Signaling in Colorectal Car
- Page 127: Table W2. Detailed Somatic Events o
- Page 131 and 132: Identification of RCC2 as a prognos
- Page 133 and 134: INTRODUCTIONMicrosatellite instabil
- Page 135 and 136: unselected series of primary tumors
- Page 137 and 138: specificity, i.e. that they only am
- Page 139 and 140: On the assumption that DNA repair a
- Page 141 and 142: In order to ensure that gene mutati
- Page 143 and 144: Figure 2. Mutation frequency differ
- Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
- Page 147 and 148: Multivariate analysesA multivariate
- Page 149 and 150: When comparing our findings of muta
- Page 151 and 152: The test series included a low numb
- Page 153 and 154: entering M-phase remains to be seen
- Page 155: 12. Duval A, Reperant M, Hamelin R
- Page 159: AppendicesAppendix I:List of abbrev
- Page 163 and 164: Critical Reviews TM in Oncogenesis,
- Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
- Page 167 and 168: TARGET GENES OF MSI COLORECTAL CANC
- Page 169 and 170: TARGET GENES OF MSI COLORECTAL CANC
- Page 171 and 172: TARGET GENES OF MSI COLORECTAL CANC
- Page 173 and 174: TARGET GENES OF MSI COLORECTAL CANC
- Page 175 and 176: TARGET GENES OF MSI COLORECTAL CANC
- Page 177 and 178: TARGET GENES OF MSI COLORECTAL CANC
- Page 179 and 180: TARGET GENES OF MSI COLORECTAL CANC
- Page 181 and 182: TARGET GENES OF MSI COLORECTAL CANC
- Page 183 and 184: TARGET GENES OF MSI COLORECTAL CANC
- Page 185 and 186: TARGET GENES OF MSI COLORECTAL CANC
- Page 187 and 188: TARGET GENES OF MSI COLORECTAL CANC
- Page 189 and 190: TARGET GENES OF MSI COLORECTAL CANC
- Page 191: TARGET GENES OF MSI COLORECTAL CANC